EUROPEAN NEUROPSYCHOPHARMACOLOGY

European Neuropsychopharmacology is a distinguished international peer-reviewed journal published by Elsevier in the Netherlands, identified by the ISSN 0924-977X. As a monthly publication indexed in the Science Citation Index (SCI), it holds a 2022 impact factor of 5.4 and is typically ranked in the second or third quartile of the medical and neuroscience categories according to the Chinese Academy of Sciences journal rankings. The journal is dedicated to the field of neuropsychopharmacology, encompassing both basic and clinical research on mental disorders such as depression, schizophrenia, and anxiety. Its scope includes the elucidation of pharmacological mechanisms, the evaluation of clinical trials, and neurobiological investigations, with a strong emphasis on interdisciplinary collaboration and translational medicine. While the journal is not open access and maintains rigorous peer review standards that can result in competitive submission processes and extended review cycles, it remains a high-quality venue for publishing original research and comprehensive reviews. Consequently, it serves as a reputable platform for researchers in neuroscience and psychiatry seeking to disseminate significant findings to a specialized academic audience.